Maple Grove, MN – According to filings with the U.S. Securities and Exchange Commission, 4C Medical Technologies is raising $20,000,000.00 in a new round of investment. Sources indicate as part of senior management President and Chief Executive Officer, Robert Thatcher played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About 4C Medical Technologies

4C Medical Technologies, Inc. is a medical device company developing a novel minimally invasive solution for the treatment of mitral regurgitation (MR). We are the first transcatheter MR therapy that directly addresses mitral regurgitation without replacing the native mitral valve, thus preserving the native mitral annulus and left ventricle.

To learn more about 4C Medical Technologies, visit http://www.4cmed.com/

Contact:
Robert Thatcher, President and Chief Executive Officer
612-599-0650
rthatcher@4cmed.com
https://www.linkedin.com/in/robert-thatcher-7b2b6515/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved